chrisvoncsefalvay/vaers-outcomes huggingface dataset:
After my second dose I had excruciating chest pain, unlike anything I?ve ever experienced before. It began on the first night of injection and went away within a few hours. Any weight on my chest made it worse. This most recent time was the day after my booster shot. This time the pain came and went, I felt extremely light headed like I was going to faint and was extremely out of breath. It is now two days after the shot and I still feel weak. My chest feels right and my lymph nodes are swollen and painful in my armpits.
This was my second shot.right arm didn't stop being terribly painful for a long time.   By day 10 it started moving to slowing my walking, some pain.  But these symptoms were masked because I was put on  low dose LDN for other issues.  After two weeks the LDN was stopped due to itching and then my pain increased more.  My walking was limited to stairs one at a time, hard to reach, hard to bend,  hard to get  in and out of bed.  My strength was weak, my grip strength week,  I was dropping things.  I hurt.  A lot of nerve pain, fingers stiffening.  found myself taking naps to ease the pain.  I couldn't drive since my arms were painful and my neck too stiff to turn.  I was a mess.  By the beginning of august finally the symptoms started waning.  I was back on an lower dose of LDN still I started itching so another break.  For two weeks I as getting better and now I am plateaued or getting worse.  Who knows whY   did I try to move to much?    There is a lot I can't do.  My fingers have loosened for the most part so I can use the computer.  My walking is getting better so I am almost up to speed and walking farther distances but lately my knees are hurting a little why?   Today my shoulders burn like ther are knives into them.  that had mostly stopped.  Somedays my skin burns.   Pain moves from palce to place and most of these symptoms are very different from the few I had left before the vaccine.   I  want to hike.  I want to bike,  I want t golf,  I want to play tennis.  I could before the  shot.   I had blood workd done and everything is basically perfect or very good.
With the first 8 hours, I had the typical symptoms including aches, chills, fever, pain throughout arm. The next day, sysmptoms worsened, with a fever of 101, and increased pain in my arm. It is now April 9, 2021 and my fever is gone but my arm feel numb and I have swelling in my arm pit by lymph nodes and painful to touch. I feel like my vaccine arm is not as responsive and slow. I feel tired, short of breath when I walk which keep me from my usual workout routine.  I work out three times a week and before the vaccine, considered myself to be in very good health. I did have Covid 12/31/20 and my symptoms were far more mild than what I experienced taking this vaccine.
Information has been received from a pharmacist concerning a 21 year old female with no medical history and drug reactions/allergies to SULFA, who on 04-DEC-2007 was vaccinated with her first dose of Gardasil (lot # not reported).  Concomitant therapy included hormonal contraceptives (unspecified).  On an unspecified date, three weeks prior to receiving vaccine the patient received the Flu vaccine.  On an unspecified date within a few weeks post the patients vaccination with Gardasil, she developed severe joint swelling with fluid retention in the joints as well as a 24 pounds weight gain.  On an unspecified date, the patient was seen in the office.  Laboratory results from an unspecified date, unspecified thyroid and rheumatology blood tests which were reported to be negative.  The patient was referred to rheumatologist, and on an unspecified date, was diagnosed with a viral infection which the rheumatologist felt was not related to Gardasil.  At the time of this report, the patient had not recovered.  No other information was provided.  Additional information has been requested.
Acute onset of redness, edema, pain and itching about 2 cm below the injection site that started 12-24 hours after injection.
Fever with mild seizure within 2-3 days of vaccination. Dr. himself diagnosed him as developmental delay on 6-6-2003. Later on we found in him that he was not able to communicate properly, writing in the air, laughing himself without reason, he do not know about his surroundings, not playing with other kids, repeated his grade 1, and concluded by school officials as autistic kid.  5/23/2008 MR received from PCP for OVs 3/22/1999-6/2003.  Normal exam with URI sx on 3/22/99. Developmental delays noted 2/13/2003 with speech and occupational tx services recommended. Significant verbal communication and inter-relationship problems as well refusal to urinate in school toilet noted. 7/28/2008 MR received form parent which show severe receptive and expressive language delays as well as a mild articulation disorder. Follow-up: He is 12 years of age, he is fifth grader, he has been held back one grade lower, he does not have communication skills. He does not know responsibility, he does not talk himself. Some body force him to say some thing, then he say 'yes' or 'no'. Some time he talks himself on his own word and do some weird things on his own world. This is a big tragedy for us, he does not talk or play with his sibling and not talk in the class every time he shuts his mouth and keep him quite. I am totally confident that five (5) shots(vaccines) in a single day had hurt him.
At about 10:00 p.m. on March 10 patient lost her balance and fell, bumping her head in the process. Residential care staff called emergency services. EMTs detected somewhat elevated heart rate (140+ BPM) and temperature (approximately 102 degrees) and recommended she go to the ER. She was attended to and tests were administered to detect any underlying infections. Tests were all negative. Patient was kept overnight for observation. By Thursday, March 11, her heart rate and temperature were normal and she was discharged just after mid-day. She has had no lingering effects post-hospitalization.
This spontaneous report was received from a healthcare worker (who is a medical assistant) refers to an unspecified patients of unknown age and gender. The patients medical history and concurrent conditions were not reported. The healthcare worker reported that multiple unspecified patients were vaccinated with improperly stored oral, ROTATEQ lot # L004453 exp:27-MAY-2016. The vaccine was stored at 47F and administered within a time frame of 10 minutes. No adverse effects reported. No product quality complaint (PQC) was involved. This is one of the several reports received from the same reporter. Additional information has been requested.
my arm hurts/arm achy; shoulder are so achy; This case was reported by a consumer and described the occurrence of pain in arm in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On 23rd August 2021, the patient received the 1st dose of Shingles vaccine. On 25th August 2021, 2 days after receiving Shingles vaccine, the patient experienced pain in arm, and shoulder pain. On an unknown date, the outcome of the pain in arm and shoulder pain were not recovered/not resolved.   It was unknown if the reporter considered the pain in arm and shoulder pain to be related to Shingles vaccine.  Additional case details were reported as the case was reported by patient. The age at vaccination was not reported. The patient got 1st Shingles shot 2 days ago from the day of reporting.  The needle did not hurt too bad but patient's arm hurt, at the time of reporting.  The patient's arm and shoulder were so achy. No contact details were available.
The patient received the Td vaccine and 24 hours later experienced swelling, redness and itchiness at left arm (site of the injection). Follow up on 06/18/04: Patient's doctor was contacted and stated that the patient recovered.
Fatigue, New loss of taste or smell, Congestion or runny nose and Nausea or vomiting
had two vaccinations for shingles after having it twice / new case case of shingles; paralyzed my left arm and my left side of my back, underArm and chest; new case of shingles; pain is still excruciating; This case was reported by a consumer via interactive digital media and described the occurrence of vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   Co-suspect products included Herpes zoster (Shingles vaccine) for prophylaxis.   The patient's past medical history included shingles.   On an unknown date, the patient received the 1st dose of Shingles vaccine and the 2nd dose of Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine and Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant), paralysis (serious criteria GSK medically significant), shingles and pain. The patient was treated with ambiguous medication nos (Oxy (Nos)). On an unknown date, the outcome of the vaccination failure, paralysis, shingles and pain were unknown.   It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingles vaccine and Shingles vaccine. It was unknown if the reporter considered the paralysis and pain to be related to Shingles vaccine.  Additional details were provided as follows: The case was reported by the patient himself. The age at vaccination was not reported. The patient started with new case of Shingles in third week, which had all but paralyzed left arm and left side of back, underarm and chest. The pain was still excruciating and did not stop even with Oxy. The patient stated that vaccine did not prevents shingles. This case was considered as suspected vaccination failure as details regarding vaccine and an event onset were unknown at the time of reporting. The information regarding consent to follow up was not reported.
No adverse event; First dose on 21-Jan-2021 and second dose on 04-Mar-2021; This spontaneous case was reported by a patient and describes the occurrence of INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (First dose on 21-Jan-2021 and second dose on 04-Mar-2021) and NO ADVERSE EVENT (No adverse event) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 014M20A and 043L20A) for COVID-19 prophylaxis.     The patient's past medical history included Esophageal dilation procedure. Concurrent medical conditions included GERD (Esophageal dilation), Anxiety, Allergic rhinitis and Schatzki's ring (Esophageal dilation). Concomitant products included LEVOCETIRIZINE DIHYDROCHLORIDE (ALLEGRA [LEVOCETIRIZINE DIHYDROCHLORIDE]) for Allergy, SERTRALINE for Anxiety, OMEPRAZOLE for GERD.   On 21-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 04-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 04-Mar-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (First dose on 21-Jan-2021 and second dose on 04-Mar-2021). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (First dose on 21-Jan-2021 and second dose on 04-Mar-2021) and NO ADVERSE EVENT (No adverse event) outcome was unknown.            On 22-Dec-2021, patient took 3rd dose of Pfizer vaccine (lot no.: FF2590) in arm.  On 14-Jul-2022, patient took 4th dose of Pfizer vaccine (lot no.: FP4554) in arm.  On 15-Nov-2022, patient took 5th dose of Pfizer vaccine (lot no.: GJJ6665) in arm.  On an unknown date in Mar-2023, patient was tested positive for COVID-19.  A day after being tested COVID-19 positive, patient started Paxlovid. Patient followed package instructions and took the entire course. By day 7, the patient was symptom free. On day 10, the symptoms of COVID appeared again and was tested positive for COVID until day 18.  No treatment medications were reported.
I had flare of both my colitis and uveitis three days after getting my vaccine. It took a month for me to start feeling better.
Slightly sore shoulder; This is a spontaneous report from a non-contactable consumer, the patient. A 55-year-old male patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EN6207) via unspecified route of administration in left arm on 17Mar2021 at 14:15 (at the age of 55-year-old) as a single dose for COVID-19 immunisation. Medical history not reported. It was reported that the patient had no any allergies to medications, food, or other products. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested positive for COVID-19. It was reported that the patient did not received any other vaccines within 4 weeks prior to the COVID vaccine. Concomitant medications included amlodipine besylate (MANUFACTURER UNKNOWN), losartan (MANUFACTURER UNKNOWN), rosuvastatin (MANUFACTURER UNKNOWN) and METFO. On 18Mar2021, the patient experienced slightly sore shoulder. No treatment was received for the event. The clinical outcome of slightly sore shoulder was recovered on an unknown date in 2021.  No follow-up attempts are needed. No further information is expected.
This spontaneous report as received from a pharmacist refers to a patient of unknown age and gender. Pertinent medical history, concurrent conditions, drug reactions or allergies were not reported. On 01-JUN-2015 the patient was vaccinated with an expired dose of PNEUMOVAX 23 lot # K004281, expiration date 22-MAR-2015 (dose, dose number, route and anatomical location were unspecified). Concomitant therapies were not reported. No adverse effects reported. Additional information has been requested.
dose administered from a vial that was greater then 12 hours post puncture at room temperature; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (dose administered from a vial that was greater then 12 hours post puncture at room temperature) in a 31-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012F21A) for COVID-19 vaccination.     No Medical History information was reported.    On 07-Oct-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 07-Oct-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (dose administered from a vial that was greater then 12 hours post puncture at room temperature). On 07-Oct-2021, EXPIRED PRODUCT ADMINISTERED (dose administered from a vial that was greater then 12 hours post puncture at room temperature) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medications were provided. No treatment medications were provided.   This case was linked to MOD-2021-354372, MOD-2021-354432, MOD-2021-354712 (Patient Link).
A report was received from a non healthcare professional on Nov 10 2005, concerning a male vaccinee aged approximately 85 years old. The vaccine's medical history or concomitant medications was unknown by the reporter. On an unknown date, the vaccinee received Fluvirin (Batch 61503). On an unknown date the vaccinee developed localized cellulitis and swelling at the injection site. The vaccinee is currently hospitalised and his symptoms are persisting. Follow up information will be sought.
Cold; Cough; Stuffy nose; fever; This spontaneous case was reported by a consumer and describes the occurrence of NASOPHARYNGITIS (Cold), COUGH, NASAL CONGESTION, and fever in a 64-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 048A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 02-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 28-Apr-2021, the patient experienced NASOPHARYNGITIS (Cold), COUGH, NASAL CONGESTION, and fever. At the time of the report, NASOPHARYNGITIS (Cold), COUGH (Cough), NASAL CONGESTION, and fever outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) was unknown.       No concomitant medication information was provided. No lab data has been provided by the reporter. No treatment product information was provided.
10 hours after the shot I had hives which turned into a sensation of burning of the skin that lasted 18 hours. 32  hours after the vaccination experienced tingling and numbness throughout my entire body.
When administering vaccine, the needle malfunctioned. The needle was securely attached to syringe and vaccine spilled out the side of syringe
Information has been received from a consumer concerning her husband a 91 year old male who on unspecified dates was vaccinated subcutaneously with ZOSTAVAX (Merck) (lot# not reported). On an unspecified date, after vaccination the patient started coughing. An X-Ray showed that "there is something on his lung". It was also reported that the patient sought unspecified medical attention. No outcome was provided. Additional information has been requested.
11SEP95 severe joint/body aches; pt states the discomfort inhibited daily routine; no inc temp, rash or arthritis; pt states this episode lasted 2 1/2-3 days
Cough, felt throat tightening, tachy post administration. Adm 50mg diphenhydramine po @ 0840. BP 160/70, HR 147. Patient did not want epi administered. Patient's condition did not improve, EMS contacted.
Information was received from a nurse concerning a 4th grade male student who on 03 JUN 1996 was vaccinated with a dose of Varicella vaccines.  In mid DEC 2004 the student developed chickenpox.  According to the school nurse the were 58 other elementary school students who developed chickenpox in mid DEC 2004 and 34 of them had previously been vaccinated with a dose of Varicella.  Unspecified medical attention was sought.  There was no information regarding the present status of the student.  No product quality complaint was involved.  Additional information was requested.
jittery; headache; nausea; Fever of 100.1F (3 degrees warmer than typical temperature).; arm really sore; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 19-Feb-2021 and was forwarded to Moderna on 19-Feb-2021.    This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (arm really sore), FEELING JITTERY (jittery), PYREXIA (Fever of 100.1F (3 degrees warmer than typical temperature).), HEADACHE (headache) and NAUSEA (nausea) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030M20A) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included OMEPRAZOLE for an unknown indication.   On 16-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 17-Feb-2021, the patient experienced PAIN IN EXTREMITY (arm really sore) and PYREXIA (Fever of 100.1F (3 degrees warmer than typical temperature).). On 19-Feb-2021, the patient experienced FEELING JITTERY (jittery), HEADACHE (headache) and NAUSEA (nausea). At the time of the report, PAIN IN EXTREMITY (arm really sore) outcome was unknown and FEELING JITTERY (jittery), PYREXIA (Fever of 100.1F (3 degrees warmer than typical temperature).), HEADACHE (headache) and NAUSEA (nausea) had not resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 17-Feb-2021, Pyrexia: 100.1f (High) 100.1F. On 19-Feb-2021, Pyrexia: 98.1f (normal) 98.1F.         Treatment information was provided as acetaminophen.
COVID-19 Treatment with Paxlovid from 07Dec2022 to 12Dec2022; COVID-19 Treatment with Paxlovid from 07Dec2022 to 12Dec2022; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 66-year-old male patient received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), on 17Sep2022 at 11:00 as dose 5 (booster), single (Batch/Lot number: unknown) at the age of 66 years, in left arm for covid-19 immunisation; BNT162b2 (BNT162B2), on 05Mar2021 at 08:00 as dose 1, single (Lot number: E6202), in right arm, on 26Mar2021 at 14:00 as dose 2, single (Lot number: FR8727), in left arm, on 24Sep2021 at 12:00 as dose 3 (booster), single (Lot number: FC3184), in left arm and on 20May2022 at 10:00 as dose 4 (booster), single (Lot number: FJ4989), in right arm for covid-19 immunisation. The patient's relevant medical history included: "Exercise-induced asthma" (unspecified if ongoing); "coronary disease" (unspecified if ongoing); "celiac disease" (unspecified if ongoing); "seasonal allergies" (unspecified if ongoing); "acid reflux" (unspecified if ongoing). The patient has no known allergies.The patient took concomitant medications. The following information was reported: COVID-19 (medically significant), VACCINATION FAILURE (medically significant) all with onset 2022, outcome "not recovered" and all described as "COVID-19 Treatment with Paxlovid from 07Dec2022 to 12Dec2022". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: (unspecified date) Positive; (Dec2022) Positive, notes: positive test 3 days after finishing Paxlovid medication. Therapeutic measures were taken as a result of covid-19, vaccination failure including Paxlovid.  The information on the batch/lot number for BNT162b2, BNT162b2 omi ba.4-5 has been requested and will be submitted if and when received.
01/11/19 Patient called and reported her left deltoid developed a large reddened area covering her complete deltoid muscle. It was tender to touch and warm to touch. Symptoms developed during early am on 1/9/19. Pt reported no fever, no itching and discomfort relieved with OTC TYLENOL. Reddened area decreased in deltoid but appeared below elbow. Will continue OTC TYLENOL as needed. 1/12/19 symptoms resolved now.
3PM on day of vaccination 4/26/2021 patient experienced soreness, swelling, itchiness at injection site and also said it felt hard and warm to the touch.  I advised her to take Benadryl, Ibuprofen or Tylenol  and to apply a cold compress.  At 7:30 pm she reported that the site was not spreading, but still swollen and hot.   I rechecked in with patient 4/27/2021 and she said that her arm was very, very sore from shoulder to elbow, but that the swelling had gone down and the itching was gone.  She will continue to monitor, but the adverse event seemed to be improving.
Patient fainted after injection. He stated he has a history of fainting with any vaccine, not because of vaccine but because of fear of needles. Patient laid on  floor until he felt better then moved to a chair outside the imz room  to continue monitoring. He fainted again and was moved back to imz room. He laid on the floor for about 10 minutes until he felt better then moved back to chair outside room. Remained there for 20 minutes and felt he was fine to leave.
I WENT TO CONVENTION CENTER UNDER HEALTH DEPARTMENT . I WAS GIVEN AN INJECTION INTO MY RIGHT ARM. SHE BUNCHED THE SKIN. I NOTED FLUID DRIPPING DOWN MY ARM AT THE END OF THE INJECTION. I ASKED IF I GOT THE DOSE. SHE SAID YES. SHE THEN SAID AND YOU GET A FREE MASSAGE AND BEGAN TO MASSAGE IT IN. WHEN FINISHED I LEFT AND NOTED A BULGE IN THE AREA WHERE THE SHOT WAS GIVEN. I BELIEVE THE INJECTION WAS GIVEN SUBCUTANEOUSLY AND NOT INTRAMUSCULAR.
Headache began about 5 hours after getting vaccine.  Chills, fever ranging from 100 - 102 degrees, terrible body aches and pain, and worsening headache lasted until about 10:00 p.m. the following day and then started to subside.  Weak and tired on 2/19.   Felt like having Covid all over again only worse because it came on suddenly. (Had Covid in March 2020).